From Alchemy to IPO: The Business of Biotechnology
Genomics will make possible the kind of customization that undermines the drug industry's blockbuster mentality. But can Big Pharma kick the habit?
The Human Genome Project is in the news. But entrepreneurs are already catching the next wave - 3-D protein structures. The payoff will be drug discovery at genomic speed.
Biotechnology: Firm set to mine Framingham Heart Study.
DNA-based PCs? Doubtful. But DNA might do some computing-while assembling nanostructures.